Moleculin Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.

About MBRX

Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses. 

CEO
Walter V. Klemp
CEOWalter V. Klemp
Employees
17
Employees17
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2015
Founded2015
Employees
17
Employees17

MBRX Key Statistics

Market cap
8.25M
Market cap8.25M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
Dividend yield
Average volume
717.33K
Average volume717.33K
High today
$0.75
High today$0.75
Low today
$0.5501
Low today$0.5501
Open price
$0.68
Open price$0.68
Volume
1.31M
Volume1.31M
52 Week high
$4.71
52 Week high$4.71
52 Week low
$0.3975
52 Week low$0.3975

People also own

Based on the portfolios of people who own MBRX. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.